Terms: = Uterine cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Prognosis
32 results:
1. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
Li N; Chen Q; Li B
Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
[TBL] [Abstract] [Full Text] [Related]
2. Tumor Microenvironment CD8 T and Treg Cells-related Genes Signature Distinguishes Distinct prognosis and Targeted Therapies Response in Endometrial cancer.
Liu X; Feng D; Wang W; Liang J; Yu H; Ling B
J Immunother; 2023 Jun; 46(5):178-191. PubMed ID: 37098928
[TBL] [Abstract] [Full Text] [Related]
3. Multimolecular characteristics and role of brca1 interacting protein C-terminal helicase 1 (BRIP1) in human tumors: a pan-cancer analysis.
Wang R; Zhang J; Cui X; Wang S; Chen T; Niu Y; Du X; Kong J; Wang L; Jiang Y
World J Surg Oncol; 2023 Mar; 21(1):91. PubMed ID: 36907870
[TBL] [Abstract] [Full Text] [Related]
4. Prevalence and Prognostic Relevance of Homologous Recombination Repair Gene Mutations in uterine Serous Carcinoma.
Dong L; Wang T; Li N; Yao H; Ying J; Wu L; Yuan G
Cells; 2022 Nov; 11(22):. PubMed ID: 36428992
[TBL] [Abstract] [Full Text] [Related]
5. Pan-cancer analysis of the prognostic and immunological role of brca1-associated protein 1 gene (BAP1): Friend or foe?
Wang T; Zhu T; Zhang Y; Bai J; Xue Y; Xu G; Lu L; Peng Q
Gene; 2022 Oct; 840():146765. PubMed ID: 35905855
[TBL] [Abstract] [Full Text] [Related]
6. Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score-matched analysis.
Nero C; Pasciuto T; Cappuccio S; Corrado G; Pelligra S; Zannoni GF; Santoro A; Piermattei A; Minucci A; Lorusso D; Fanfani F; Scambia G
Cancer; 2022 Aug; 128(15):2898-2907. PubMed ID: 35617463
[TBL] [Abstract] [Full Text] [Related]
7. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical cancer.
Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
[TBL] [Abstract] [Full Text] [Related]
8. Construction and validation of a prognostic model for stage IIIC endometrial cancer patients after surgery.
Yang XL; Huang H; Kou LN; Lai H; Chen XP; Wu DJ
Eur J Surg Oncol; 2022 May; 48(5):1173-1180. PubMed ID: 34972620
[TBL] [Abstract] [Full Text] [Related]
9. Genomic mutation features identify distinct BRCA-associated mutation characteristics in endometrioid carcinoma and endometrioid ovarian carcinoma.
Cao C; Yu R; Gong W; Liu D; Zhang X; Fang Y; Xia Y; Zhang W; Gao Q
Aging (Albany NY); 2021 Nov; 13(22):24686-24709. PubMed ID: 34837690
[TBL] [Abstract] [Full Text] [Related]
10. Expression of selected molecular factors in two types of endometrial cancer.
Markowska A; Gryboś A; Marszałek A; Bednarek W; Filas V; Gryboś M; Markowska J; Mądry R; Więckowska B; Nowalińska D; Szarszewska M
Adv Clin Exp Med; 2021 Oct; 30(10):1057-1064. PubMed ID: 34510841
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database.
De Nonneville A; Zemmour C; Frank S; Joly F; Ray-Coquard I; Costaz H; Classe JM; Floquet A; De la Motte Rouge T; Colombo PE; Sauterey B; Leblanc E; Pomel C; Marchal F; Barranger E; Savoye AM; Guillemet C; Petit T; Pautier P; Rouzier R; Gladieff L; Simon G; Courtinard C; Sabatier R
Gynecol Oncol; 2021 Oct; 163(1):64-71. PubMed ID: 34294414
[TBL] [Abstract] [Full Text] [Related]
12. Successful treatment of a patient with brain metastases from endometrial cancer using Niraparib: a case report.
Wang Q; Zhang F; Gao H; Xu Y
Ann Palliat Med; 2021 Jan; 10(1):818-827. PubMed ID: 33545804
[TBL] [Abstract] [Full Text] [Related]
13. Aberrant Promoter Hypermethylation of RASSF1a and brca1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma.
S SK; Swamy SN; Premalatha CS; Pallavi VR; Gawari R
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3001-3005. PubMed ID: 31653147
[TBL] [Abstract] [Full Text] [Related]
14. CircPLEKHM3 acts as a tumor suppressor through regulation of the miR-9/brca1/DNAJB6/KLF4/AKT1 axis in ovarian cancer.
Zhang L; Zhou Q; Qiu Q; Hou L; Wu M; Li J; Li X; Lu B; Cheng X; Liu P; Lu W; Lu Y
Mol Cancer; 2019 Oct; 18(1):144. PubMed ID: 31623606
[TBL] [Abstract] [Full Text] [Related]
15. [Expression of SMARCA4(BRG1) and SMARCB1(INI1) in dedifferentiated and undifferentiated endometrial carcinomas and their correlations with clinicopathological features].
Bi R; Yu L; Tu XY; Ge HJ; Cheng YF; Chang B; Cai X; Jiang WH; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):590-595. PubMed ID: 31422588
[No Abstract] [Full Text] [Related]
16. Carcinoid tumor of lung and BRCA mutation: a case report.
Shariff MZ; Curras-Martin D; Campbell N; Gupta V; Mikhail JD; Levitt MJ; Hossain MA
J Med Case Rep; 2019 May; 13(1):132. PubMed ID: 31039815
[TBL] [Abstract] [Full Text] [Related]
17. Studies on selected molecular factors in endometrial cancers.
Markowska A; Szarszewska M; Żurawski J; Sajdak S; Knapp P; Gryboś A; Olejek A; Bednarek W; Roszak A; Jóźwik M; Marszałek A; Filas V; Wójcik-Krowiranda K; Mądry R; Markowska J; Sozański R
Adv Clin Exp Med; 2018 Oct; 27(10):1417-1424. PubMed ID: 30277666
[TBL] [Abstract] [Full Text] [Related]
18. Complete Remission Following Pembrolizumab in a Woman with Mismatch Repair-Deficient Endometrial cancer and a Germline
Dizon DS; Dias-Santagata D; Bregar A; Sullivan L; Filipi J; DiTavi E; Miller L; Ellisen L; Birrer M; DelCarmen M
Oncologist; 2018 Jun; 23(6):650-653. PubMed ID: 29472312
[TBL] [Abstract] [Full Text] [Related]
19. Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma.
García-Sanz P; Triviño JC; Mota A; Pérez López M; Colás E; Rojo-Sebastián A; García Á; Gatius S; Ruiz M; Prat J; López-López R; Abal M; Gil-Moreno A; Reventós J; Matias-Guiu X; Moreno-Bueno G
Int J Cancer; 2017 Apr; 140(7):1551-1563. PubMed ID: 27997699
[TBL] [Abstract] [Full Text] [Related]
20. Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study.
Pulford DJ; Harter P; Floquet A; Barrett C; Suh DH; Friedlander M; Arranz JA; Hasegawa K; Tada H; Vuylsteke P; Mirza MR; Donadello N; Scambia G; Johnson T; Cox C; Chan JK; Imhof M; Herzog TJ; Calvert P; Wimberger P; Berton-Rigaud D; Lim MC; Elser G; Xu CF; du Bois A
BMC Med Ethics; 2016 Oct; 17(1):63. PubMed ID: 27769273
[TBL] [Abstract] [Full Text] [Related]
[Next]